Cargando…

Can Serum ICAM 1 distinguish pancreatic cancer from chronic pancreatitis?

BACKGROUND AND AIM: Pancreatic cancer is the fourth leading cause of cancer-related death worldwide, with an overall 5-year survival of <5% mainly due to presence of advanced disease at time of diagnosis. Therefore development of valid biomarkers to diagnose pancreatic cancer in early stages is a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohamed, Amal, Saad, Yasmin, Saleh, Doaa, Elawady, Rehab, Eletreby, Rasha, khairalla, Ahmed, Badr, Eman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454615/ https://www.ncbi.nlm.nih.gov/pubmed/27892682 http://dx.doi.org/10.22034/APJCP.2016.17.10.4671

Ejemplares similares

Multi-modality imaging features distinguish pancreatic carcinoma from mass-forming chronic pancreatitis of the pancreatic head
por: Ruan, Zhibing, et al.
Publicado: (2018)

A Rationally Designed ICAM1 Antibody Drug Conjugate for Pancreatic Cancer
por: Huang, Jing, et al.
Publicado: (2020)

Screening for maternal cytomegalovirus infection during pregnancy and pregnancy outcome in patients with liver disease: an observational study
por: Eletreby, Rasha, et al.
Publicado: (2023)

Autoimmune pancreatitis can develop into chronic pancreatitis
por: Maruyama, Masahiro, et al.
Publicado: (2014)

Early diagnosis of serum sICAM-1 and sRAGE in severe acute pancreatitis, and efficacy and prognosis prediction of glutamine combined with ulinastatin
por: Shan, Lini, et al.
Publicado: (2021)

Identifying Effective Biomarkers for Accurate Pancreatic Cancer Prognosis Using Statistical Machine Learning
por: Abu-Khudir, Rasha, et al.
Publicado: (2023)

Clinical Value of Mean Platelet Volume to Platelet Ratio (MPR) in Distinguishing Mass-Forming Chronic Pancreatitis and Pancreatic Cancer
por: Wang, Han-Xuan, et al.
Publicado: (2023)

The Role of MRI Pancreatic Protocol in Assessing Response to Neoadjuvant Therapy for Patients With Borderline Resectable Pancreatic Cancer
por: Hussien, Nervana, et al.
Publicado: (2022)

Ellagic acid regulates hyperglycemic state through modulation of pancreatic IL-6 and TNF- α immunoexpression
por: Elbandrawy, Manal M., et al.
Publicado: (2022)

Serum miR-210-3p can be used to differentiate between patients with pancreatic ductal adenocarcinoma and chronic pancreatitis
por: Guz, Małgorzata, et al.
Publicado: (2021)

Distinguishable Prognostic Signatures and Tumor Immunogenicity Between Pancreatic Head Cancer and Pancreatic Body/Tail Cancer
por: Ge, Weiyu, et al.
Publicado: (2022)

Study of the role of tumor necrosis factor-α (–308 G/A) and interleukin-10 (–1082 G/A) polymorphisms as potential risk factors to acute kidney injury in patients with severe sepsis using high-resolution melting curve analysis
por: Hashad, Doaa I., et al.
Publicado: (2016)

Serum Soluble Intercellular Adhesion Molecule-1 (sICAM-1): A Novel Potential Biomarker in Severe Acne Vulgaris
por: Mustafa, Amany Ibrahim, et al.
Publicado: (2022)

Comparative proteomic profiling of the serum differentiates pancreatic cancer from chronic pancreatitis
por: Saraswat, Mayank, et al.
Publicado: (2017)

Ultrasound-microbubble targeted delivery of ICAM-1 in mouse model of peripheral arterial disease
por: Badr, Lena
Publicado: (2015)

Cyst fluid metabolites distinguish malignant from benign pancreatic cysts
por: Shi, Jiaqi, et al.
Publicado: (2021)

Cyst fluid glycoproteins accurately distinguishing malignancies of pancreatic cystic neoplasm
por: Cui, Ming, et al.
Publicado: (2023)

Therapeutic potential of chrysin nanoparticle-mediation inhibition of succinate dehydrogenase and ubiquinone oxidoreductase in pancreatic and lung adenocarcinoma
por: Ragab, Eman M., et al.
Publicado: (2022)

Tumour-derived Interleukin 35 promotes pancreatic ductal adenocarcinoma cell extravasation and metastasis by inducing ICAM1 expression
por: Huang, Chongbiao, et al.
Publicado: (2017)

Liquid biopsy, using a novel DNA methylation signature, distinguishes pancreatic adenocarcinoma from benign pancreatic disease
por: Vrba, Lukas, et al.
Publicado: (2022)

Design Flaws in the Study of Distinguishing Diabetes Associated With Chronic Pancreatitis and Type 2 Diabetes Mellitus
por: Liu, Yu, et al.
Publicado: (2019)

Evaluation of GALAD Score in Diagnosis and Follow-up of Hepatocellular Carcinoma after Local Ablative Therapy
por: Eletreby, Rasha, et al.
Publicado: (2023)

Characterization of the function of intercellular adhesion molecule (ICAM)-3 and comparison with ICAM-1 and ICAM-2 in immune responses
Publicado: (1994)

Outcome and prognostic markers of cirrhotic and non-cirrhotic patients admitted to a hepatology ICU in a tertiary care university hospital
por: Abdellatif, Zeinab, et al.
Publicado: (2022)

Distinguishing pancreatic solid serous cystadenomas from nonfunctional pancreatic neuroendocrine tumors by computed tomography: A propensity score analysis
por: Fang, Xu, et al.
Publicado: (2022)

The Use of Values WNR and GNR to Distinguish between and Diagnose Different Types of Pancreatitis
por: Luo, Liwen, et al.
Publicado: (2020)

Tumor-Infiltrating Leukocyte Phenotypes Distinguish Outcomes in Related Patients With Pancreatic Adenocarcinoma
por: Link, Jason M., et al.
Publicado: (2021)

Can Pancreatic Phlegmon be Diagnosed?
por: Warshaw, Andrew L.
Publicado: (1990)

Impairment of electron transport chain and induction of apoptosis by chrysin nanoparticles targeting succinate-ubiquinone oxidoreductase in pancreatic and lung cancer cells
por: Ragab, Eman M., et al.
Publicado: (2023)

Diagnostic value of serum ICAM-1 for endometriosis: A meta-analysis
por: Li, Rong, et al.
Publicado: (2018)

Low Serum Pancreatic Amylase and Lipase Values Are Simple and Useful Predictors to Diagnose Chronic Pancreatitis
por: Oh, Hyoung-Chul, et al.
Publicado: (2017)

Lipemic serum in hyperlipidemic pancreatitis
por: Michalakis, Konstantinos, et al.
Publicado: (2009)

Can early endoscopic ultrasound predict pancreatic necrosis in acute pancreatitis?
por: Rana, Surinder S., et al.
Publicado: (2014)

Development and validation of a novel model incorporating MRI-based radiomics signature with clinical biomarkers for distinguishing pancreatic carcinoma from mass-forming chronic pancreatitis
por: Liu, Jingjing, et al.
Publicado: (2022)

A Nano-Liposomal Formulation of Caffeic Acid Phenethyl Ester Modulates Nrf2 and NF-κβ Signaling and Alleviates Experimentally Induced Acute Pancreatitis in a Rat Model
por: Shahin, Nancy Nabil, et al.
Publicado: (2022)

Pancreatitis and Pancreatic Pseudocyst
por: Al-Salem, Ahmed H.
Publicado: (2020)

Autoimmune pancreatitis presenting as a pancreatic head mass
por: Imrani, Kaoutar, et al.
Publicado: (2021)

Serum Protein Signatures Differentiating Autoimmune Pancreatitis versus Pancreatic Cancer
por: Felix, Klaus, et al.
Publicado: (2013)

Serum biomarkers for the differentiation of autoimmune pancreatitis from pancreatic ductal adenocarcinoma
por: Caba, Octavio, et al.
Publicado: (2023)

Imaging of glucose metabolism by 13C-MRI distinguishes pancreatic cancer subtypes in mice
por: Kishimoto, Shun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rqu6jtic7eom3d5at4097c5ptc